{"id":134,"date":"2016-10-03T22:48:57","date_gmt":"2016-10-03T22:48:57","guid":{"rendered":"http:\/\/23.235.211.204\/~luceome\/?p=134"},"modified":"2022-04-26T10:03:46","modified_gmt":"2022-04-26T17:03:46","slug":"luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding","status":"publish","type":"post","link":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/","title":{"rendered":"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1352px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\"><p>TUCSON, AZ &#8211; LUCEOME BIOTECHNOLOGIES a privately held biotechnology company focused on the discovery and development of its innovative proprietary assay platform today announced the award of $1.6 million in grant funding from The National Institutes of Health to further their research in high throughput screening using the KinaseSeeker&#x2122; technology. Earlier this year, Luceome was awarded a grant for $287K for research in the area of poly(ADP-ribose) detection.<\/p>\n<p><a href=\"https:\/\/luceome.com\/wp-content\/uploads\/2016\/10\/SBIR-funding.pdf\" target=\"_blank\" rel=\"noopener\">Read More<\/a><\/p>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 0px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies\" \/>\n<meta property=\"og:url\" content=\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/\" \/>\n<meta property=\"og:site_name\" content=\"Luceome Biotechnologies\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-03T22:48:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-26T17:03:46+00:00\" \/>\n<meta name=\"author\" content=\"jvista\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"jvista\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/\",\"url\":\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/\",\"name\":\"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies\",\"isPartOf\":{\"@id\":\"https:\/\/luceome.com\/#website\"},\"datePublished\":\"2016-10-03T22:48:57+00:00\",\"dateModified\":\"2022-04-26T17:03:46+00:00\",\"author\":{\"@id\":\"https:\/\/luceome.com\/#\/schema\/person\/d9f3f38276ff4ab30e08214ac616e978\"},\"breadcrumb\":{\"@id\":\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/luceome.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/luceome.com\/#website\",\"url\":\"https:\/\/luceome.com\/\",\"name\":\"Luceome Biotechnologies\",\"description\":\"Unraveling mysteries, Enabling Discoveries\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/luceome.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/luceome.com\/#\/schema\/person\/d9f3f38276ff4ab30e08214ac616e978\",\"name\":\"jvista\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/luceome.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5b9b593d899ffb34476dc9b989debbfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5b9b593d899ffb34476dc9b989debbfd?s=96&d=mm&r=g\",\"caption\":\"jvista\"},\"url\":\"https:\/\/luceome.com\/author\/jvista\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/","og_locale":"en_US","og_type":"article","og_title":"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies","og_url":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/","og_site_name":"Luceome Biotechnologies","article_published_time":"2016-10-03T22:48:57+00:00","article_modified_time":"2022-04-26T17:03:46+00:00","author":"jvista","twitter_card":"summary_large_image","twitter_misc":{"Written by":"jvista","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/","url":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/","name":"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding - Luceome Biotechnologies","isPartOf":{"@id":"https:\/\/luceome.com\/#website"},"datePublished":"2016-10-03T22:48:57+00:00","dateModified":"2022-04-26T17:03:46+00:00","author":{"@id":"https:\/\/luceome.com\/#\/schema\/person\/d9f3f38276ff4ab30e08214ac616e978"},"breadcrumb":{"@id":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/luceome.com\/luceome-biotechnologies-receives-1-9-million-in-phase-i-and-phase-ii-sbir-funding\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/luceome.com\/"},{"@type":"ListItem","position":2,"name":"Luceome Biotechnologies Receives $1.9 Million in Phase I and Phase II SBIR Funding"}]},{"@type":"WebSite","@id":"https:\/\/luceome.com\/#website","url":"https:\/\/luceome.com\/","name":"Luceome Biotechnologies","description":"Unraveling mysteries, Enabling Discoveries","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/luceome.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/luceome.com\/#\/schema\/person\/d9f3f38276ff4ab30e08214ac616e978","name":"jvista","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/luceome.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5b9b593d899ffb34476dc9b989debbfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5b9b593d899ffb34476dc9b989debbfd?s=96&d=mm&r=g","caption":"jvista"},"url":"https:\/\/luceome.com\/author\/jvista\/"}]}},"_links":{"self":[{"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/posts\/134"}],"collection":[{"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/comments?post=134"}],"version-history":[{"count":2,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/posts\/134\/revisions"}],"predecessor-version":[{"id":922,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/posts\/134\/revisions\/922"}],"wp:attachment":[{"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/media?parent=134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/categories?post=134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/luceome.com\/wp-json\/wp\/v2\/tags?post=134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}